These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17132635)

  • 1. Age at disability milestones in multiple sclerosis and history of multiple sclerosis: a unifying concept.
    Goodin D
    Brain; 2006 Dec; 129(Pt 12):e56; author reply e57. PubMed ID: 17132635
    [No Abstract]   [Full Text] [Related]  

  • 2. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of multiple sclerosis.
    Deshpande R; Kremenchutzky M; Rice GP
    Adv Neurol; 2006; 98():1-15. PubMed ID: 16400823
    [No Abstract]   [Full Text] [Related]  

  • 4. Age at onset determines the occurrence of the progressive phase of multiple sclerosis.
    Stankoff B; Mrejen S; Tourbah A; Fontaine B; Lyon-Caen O; Lubetzki C; Rosenheim M
    Neurology; 2007 Mar; 68(10):779-81. PubMed ID: 17339588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of multiple sclerosis: long-term prognostic factors.
    Renoux C
    Neurol Clin; 2011 May; 29(2):293-308. PubMed ID: 21439442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan.
    Shiraishi K; Higuchi Y; Ozawa K; Hao Q; Saida T
    Brain Dev; 2005 Apr; 27(3):224-7. PubMed ID: 15737705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression in multiple sclerosis: further evidence of an age dependent process.
    Koch M; Mostert J; Heersema D; De Keyser J
    J Neurol Sci; 2007 Apr; 255(1-2):35-41. PubMed ID: 17331540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making progress on the natural history of multiple sclerosis.
    Compston A
    Brain; 2006 Mar; 129(Pt 3):561-3. PubMed ID: 16477087
    [No Abstract]   [Full Text] [Related]  

  • 11. Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: implications for treatment.
    Pittock SJ
    Neurology; 2007 Feb; 68(7):480-1. PubMed ID: 17296911
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
    Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse, remission, and progression in multiple sclerosis.
    McDonald WI
    N Engl J Med; 2000 Nov; 343(20):1486-7. PubMed ID: 11078776
    [No Abstract]   [Full Text] [Related]  

  • 16. ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.
    Portaccio E; Zipoli V; Goretti B; Hakiki B; Nacmias B; Siracusa G; Sorbi S; Amato MP
    Acta Neurol Scand; 2009 Dec; 120(6):439-41. PubMed ID: 19804477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-specific disease courses and disability in 1000 cases of multiple sclerosis (author's transl)].
    Fischler M; Kornhuber HH; Sindermann F
    Nervenarzt; 1977 Mar; 48(3):139-44. PubMed ID: 854134
    [No Abstract]   [Full Text] [Related]  

  • 18. An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.
    Casado V; Romero L; Gubieras L; Alonso L; Moral E; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Arbizu T
    Mult Scler; 2007 Jul; 13(6):800-4. PubMed ID: 17613609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?
    Petiot V; Quantin C; Le Teuff G; Chavance M; Binquet C; Abrahamowicz M; Moreau T
    Neuroepidemiology; 2007; 28(1):56-64. PubMed ID: 17215588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical epidemiology of multiple sclerosis.
    Confavreux C; Vukusic S
    Neuroimaging Clin N Am; 2008 Nov; 18(4):589-622, ix-x. PubMed ID: 19068404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.